1 / 55

HEART-LUNG TRANSPLANTATION

HEART-LUNG TRANSPLANTATION. Overall. ISHLT. 2009. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR. ISHLT.

sef
Download Presentation

HEART-LUNG TRANSPLANTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEART-LUNG TRANSPLANTATION Overall ISHLT 2009

  2. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR ISHLT NOTE: This figure includes only the heart-lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of heart-lung transplants worldwide has declined in recent years. 2009

  3. AVERAGE CENTER VOLUMEHeart-LungTransplants: January 1, 1998 - June 30, 2008 ISHLT 2009

  4. DISTRIBUTION OF HEART-LUNG TRANSPLANTS BY CENTER VOLUMEHeart-Lung Transplants: January 1, 1998 - June 30, 2008 ISHLT 2009

  5. DISTRIBUTION OF HEART-LUNG TRANSPLANTS BY LUNG CENTER VOLUMELung Transplants: January 1, 1998 - June 30, 2008 ISHLT 2009

  6. HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival for All Ages(Transplants: January 1982 - June 2007) ISHLT 2009

  7. HEART-LUNG TRANSPLANTATION Adult Recipients ISHLT 2009

  8. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (January 1982 - June 2008) “Other” includes cancer, LAM, OB, sarcoidosis, bronchiectasis ISHLT 2009

  9. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS(Transplants: January 1982 - June 2008) ISHLT 2009

  10. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS BY ERA(Transplants: January 1982 - June 2008) “Other” includes OB (non-ReTX), Bronchiectasis, Sarcoidosis ISHLT 2009

  11. ADULT HEART-LUNG TRANSPLANTATIONIndications By Year (%) ISHLT 2009

  12. ADULT HEART-LUNG TRANSPLANTATIONIndications By Year (Number) ISHLT 2009

  13. ADULT HEART-LUNG TRANSPLANTS:AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2008 ISHLT 2009

  14. ADULT HEART-LUNG TRANSPLANTS:DIAGNOSIS DISTRIBUTION BY LOCATION Transplants between January 2000 and June 2008 ISHLT 2009

  15. ADULT HEART-LUNG TRANSPLANTS:DONOR AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2008 ISHLT 2009

  16. HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival for Adult Recipients(Transplants: January 1982 - June 2007) ISHLT 2009

  17. HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival for Adult Recipients by Era(Transplants: January 1982 - June 2007) ISHLT 2009

  18. ADULT HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1990 – June 2007) ISHLT 2009

  19. ADULT HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 1 Year(Transplants: January 1990 – June 2007) ISHLT 2009

  20. ADULT HEART-LUNG RECIPIENTS Functional Status of Surviving Recipients (Follow-ups: April 1994 – June 2008) ISHLT 2009

  21. ADULT HEART-LUNG RECIPIENTSFunctional Status of Surviving Recipients For the Same Patients(Follow-ups: April 1994 – June 2008) ISHLT 2009

  22. ADULT HEART-LUNG RECIPIENTSEmployment Status of Surviving Recipients(Follow-ups: April 1994 – June 2008) ISHLT 2009

  23. ADULT HEART-LUNG RECIPIENTS:Rehospitalization Post-transplant of Surviving Recipients(Follow-ups: April 1994 - June 2008) ISHLT 2009

  24. ADULT HEART-LUNG RECIPIENTS Induction ImmunosuppressionFor transplants between January 2001 through June 2008 ISHLT 2009 Analysis is limited to patients who were alive at the time of the follow-up

  25. ADULT HEART-LUNG RECIPIENTSInduction Immunosuppression (Transplants: January 2000 - December 2007) ISHLT 2009 Analysis is limited to patients who were alive at the time of the follow-up

  26. ADULT HEART-LUNG RECIPIENTSInduction Immunosuppression (Transplants: January 2000 - December 2007) Any Induction Polyclonal ALG/ATG OKT3 IL2R-antagonist ISHLT 2009 Analysis is limited to patients who were alive at the time of the follow-up

  27. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between January 2001 through June 2008 NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2009 Analysis is limited to patients who were alive at the time of the follow-up

  28. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression Drug Combinations at Time of Follow-upFor follow-ups between January 2001 through June 2008 NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2009 Analysis is limited to patients who were alive at the time of the follow-up

  29. POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Prevalence in Survivors within 1 Year Post-Transplant (Follow-ups: April 1994 - June 2008) ISHLT 2009

  30. POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Prevalence in Survivors within 5 Years Post-Transplant (Follow-ups: April 1994 - June 2008) ISHLT 2009

  31. Freedom from Coronary Artery Vasculopathy For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2008) ISHLT 2009

  32. Freedom from Bronchiolitis Obliterans Syndrome For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2008) ISHLT 2009

  33. Freedom from Severe Renal Dysfunction*For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2008) ISHLT 2009

  34. MALIGNANCY POST-HEART-LUNG TRANSPLANT FOR ADULTSCumulative Prevalence in Survivors(Follow-ups: April 1994-June 2008) * Recipients may have experienced more than one type of malignancy so sum of individual malignancy types may be greater than total number with malignancy. ISHLT 2009

  35. Freedom from MalignancyFor Adult Heart-Lung Recipients(Follow-ups: April 1994- June 2008) ISHLT 2009

  36. ADULT HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(Deaths: January 1992 - June 2008) ISHLT 2009

  37. ADULT HEART-LUNG TRANSPLANT RECIPIENTS: Relative Incidence of Leading Causes of Death(Deaths: January 1992 - June 2008) ISHLT 2009

  38. HEART-LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2009

  39. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNGRECIPIENTS (Transplants: January 1982 - June 2008) ISHLT 2009

  40. AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART-LUNG RECIPIENTS(Transplants: January 1982 - June 2008) ISHLT 2009

  41. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTSBy Year of Transplant Number of Transplants NOTE: This figure includes only the heart transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of pediatric heart-lung transplants worldwide has declined in recent years. ISHLT 2009

  42. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTSBy Era of Transplant Percentage of Transplants ISHLT 2009

  43. NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTS NEED TO UPDATE ISHLT 2009

  44. NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTSStratified by center volume ISHLT 2009

  45. “Other” includes Bronchiectasis, Alpha-1, and OB (non-ReTX) DIAGNOSIS IN PEDIATRIC HEART –LUNG TRANSPLANT RECIPIENTS (Transplants: 1986-2007) ISHLT NOTE: Unknown diagnoses were excluded from this tabulation. 2009

  46. PEDIATRIC HEART-LUNG TRANSPLANTS:AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2008 ISHLT 2009

  47. PEDIATRIC HEART-LUNG TRANSPLANTS:DIAGNOSIS DISTRIBUTION BY LOCATION Transplants between January 2000 and June 2008 ISHLT 2009

  48. PEDIATRIC HEART-LUNG TRANSPLANTS:DONOR AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2008 ISHLT 2009

  49. PEDIATRIC HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1990 – June 2007) ISHLT 2009

  50. PEDIATRIC HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival(Transplants: January 1982 - June 2007) ISHLT 2009

More Related